(Q57949385)
Statements
Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy (English)
José Trigo
Ricardo Hitt
Piotr Koralewski
Rainald Knecht
Nadia Amellal
Armin Schueler
José Baselga
Jan B Vermorken